PT Kalbe Farma Tbk Share Price INDONESIA S.E.
Equities
KLBF
ID1000096803
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- IDR | - |
30/04 | PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01/04 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 32,560B 2.05B 170B | Sales 2025 * | 34,951B 2.2B 183B | Capitalization | 66,839B 4.21B 349B |
---|---|---|---|---|---|
Net income 2024 * | 3,132B 197M 16.36B | Net income 2025 * | 3,496B 220M 18.26B | EV / Sales 2024 * | 1.94 x |
Net cash position 2024 * | 3,714B 234M 19.4B | Net cash position 2025 * | 4,587B 289M 23.96B | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
19.2
x | Employees | - |
Yield 2024 * |
2.28% | Yield 2025 * |
2.4% | Free-Float | 40.44% |
Managers | Title | Age | Since |
---|---|---|---|
Vidjongtius
CEO | Chief Executive Officer | 59 | 01/97/01 |
Chairman | 62 | 01/97/01 | |
Danny Natalies
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Santoso Oen
BRD | Director/Board Member | 59 | 01/00/01 |
Chairman | 62 | 01/97/01 | |
Ronny Hadiana
BRD | Director/Board Member | 52 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- KLBF Stock
- KLBF Stock